Published in J Intellect Disabil Res on August 01, 1992
Adults with genetic syndromes and cardiovascular abnormalities: clinical history and management. Genet Med (2008) 0.98
Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins. RNA Biol (2010) 0.98
Age-related changes in plasma levels of BDNF in Down syndrome patients. Immun Ageing (2010) 0.91
Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology. Curr Alzheimer Res (2016) 0.90
Alzheimer's Disease in Down Syndrome. Eur J Neurodegener Dis (2012) 0.85
Cardiovascular Disease, Single Nucleotide Polymorphisms; and the Renin Angiotensin System: Is There a MicroRNA Connection? Int J Hypertens (2010) 0.81
Lipid profiles of children with Down syndrome compared with their siblings. Pediatrics (2012) 0.81
LDL receptor expression on T lymphocytes in old patients with Down syndrome. Immun Ageing (2005) 0.76
Lipid and glucose serum levels in children with congenital heart disease. J Tehran Heart Cent (2014) 0.75
Maternal serum screening for Down's syndrome in early pregnancy. BMJ (1988) 8.65
Apolipoproteins and ischaemic heart disease: implications for screening. Lancet (1994) 6.62
Association between exposure to environmental tobacco smoke and exacerbations of asthma in children. N Engl J Med (1993) 5.56
Is it time for population-based prenatal screening for fragile-X? Lancet (1993) 3.24
Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ (1989) 2.96
Improved 125I radioimmunoassay for cotinine by selective removal of bridge antibodies. Clin Chem (1985) 2.79
Urinary cotinine as marker of breathing other people's tobacco smoke. Lancet (1984) 2.74
Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome. Br J Obstet Gynaecol (1988) 2.62
Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen (2000) 2.47
Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obstet Gynaecol (1988) 2.40
When is it appropriate to apply fetal cell isolation clinically? Am J Obstet Gynecol (1995) 2.17
An unsuccessful cotinine-assisted intervention strategy to reduce environmental tobacco smoke exposure during infancy. Am J Dis Child (1992) 1.61
Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin. Prenat Diagn (1995) 1.60
Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol (Oxf) (1991) 1.56
Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. J Clin Endocrinol Metab (1998) 1.49
Down's syndrome screening with nuchal translucency. Lancet (1997) 1.44
Prenatal screening for open neural-tube defects in Maine. N Engl J Med (1999) 1.42
Rapid detection of neonatal group B streptococcal infections by latex agglutination. J Pediatr (1980) 1.40
Why the term "carrier screening" should be abandoned. J Med Screen (1997) 1.39
Lipoprotein(a) levels in peripheral atherosclerotic disease. J Vasc Surg (1995) 1.39
Maternal serum alpha-fetoprotein, age, and Down syndrome risk. Am J Obstet Gynecol (1987) 1.39
Use of serum cotinine to assess the accuracy of self reported non-smoking. Br Med J (Clin Res Ed) (1986) 1.36
Cigarette consumption and serum cotinine in relation to birthweight. Br J Obstet Gynaecol (1987) 1.32
Population screening for haemochromatosis: a unifying analysis of published intervention trials. J Med Screen (1996) 1.31
Population screening for haemochromatosis: expectations based on a study of relatives of symptomatic probands. J Med Screen (1996) 1.29
Hereditary haemochromatosis: to screen or not. Conditions for screening are not yet fulfilled. BMJ (1999) 1.28
Hereditary haemochromatosis mutation frequencies in the general population. J Med Screen (1998) 1.27
Determination of nicotine and cotinine in human serum and urine: an interlaboratory study. Toxicol Lett (1987) 1.23
Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal (1999) 1.14
Relation of severity of maternal hypothyroidism to cognitive development of offspring. J Med Screen (2001) 1.13
Refinements in managing maternal weight adjustment for interpreting prenatal screening results. Prenat Diagn (1996) 1.11
Understanding and managing hypernatremic dehydration. Pediatr Clin North Am (1974) 1.11
Self-limited neonatal hyperparathyroidism in familial hypocalciuric hypercalcemia. J Pediatr (1987) 1.09
Prenatal screening for cystic fibrosis. Lancet (1994) 1.07
Environmental tobacco smoke exposure during infancy. Am J Public Health (1990) 1.06
Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies. Clin Chem (1998) 1.06
Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin. Prenat Diagn (1992) 1.05
Relation between maternal weight and serum alpha-fetoprotein concentration during the second trimester. Clin Chem (1981) 1.04
Simultaneous fetal and maternal cotinine levels in pregnant women smokers. Am J Obstet Gynecol (1993) 1.00
The effect of smoking in pregnancy on maternal serum alpha-fetoprotein, unconjugated oestriol, human chorionic gonadotrophin, progesterone and dehydroepiandrosterone sulphate levels. Br J Obstet Gynaecol (1990) 1.00
Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemia. N Engl J Med (1983) 0.99
Exposure to environmental tobacco smoke measured by cotinine 125I-radioimmunoassay. Clin Chem (1989) 0.99
Ingestion of charcoal lighter fluid. J Pediatr (1975) 0.97
Maternal serum unconjugated estriol levels are lower in the presence of fetal Down syndrome. Am J Obstet Gynecol (1990) 0.96
Familial congenital disorder resembling stiff-man syndrome. Am J Dis Child (1972) 0.96
Couple screening to avoid thalassemia: successful in Iran and instructive for us. J Med Screen (2005) 0.94
Reference distributions for immunoglobulins A, G, and M: a practical, simple, and clinically relevant approach in a large cohort. J Clin Lab Anal (1998) 0.93
The amnion regulates movement of fetally derived alpha-fetoprotein into maternal blood. J Lab Clin Med (1979) 0.93
Acetylcholinesterase and fetal malformations: modified qualitative technique for diagnosis of neural tube defects. Clin Chem (1981) 0.92
Deregulation of screening for alpha-fetoprotein in pregnancy. N Engl J Med (1984) 0.92
A point mutation in transthyretin increases affinity for thyroxine and produces euthyroid hyperthyroxinemia. J Clin Invest (1990) 0.91
Relapse following ampicillin treatment of acute Hemophilus influenzae meningitis. Pediatrics (1968) 0.91
Cigarette smoking-associated changes in blood lipid and lipoprotein levels in the 8- to 19-year-old age group: a meta-analysis. Pediatrics (1990) 0.91
Maternal serum alpha-fetoprotein screening for fetal Down syndrome in the United States: results of a survey. Am J Obstet Gynecol (1990) 0.91
Couple-based prenatal screening for cystic fibrosis in primary care settings. Prenat Diagn (1996) 0.90
Prevalence of abnormal thyroid function test results in patients with acute medical illnesses. Am J Med (1982) 0.90
New laboratory guidelines for serologic diagnosis of Lyme disease: evaluation of the two-test protocol. J Clin Microbiol (1996) 0.90
Regulation of rat biliary cholesterol secretion by agents that alter intrahepatic cholesterol metabolism. Evidence for a distinct biliary precursor pool. J Clin Invest (1985) 0.89
Three unusual trisomic patterns in children. Triple X plus triple E-triple X mosaic: normal XY-D trisomy mosaic; partial trisomy with E translocation. Am J Dis Child (1967) 0.89
Assigning risk for Smith-Lemli-Opitz syndrome as part of 2nd trimester screening for Down's syndrome. J Med Screen (2002) 0.89
Self-rated physical activity level during the second trimester and pregnancy outcome. Obstet Gynecol (1991) 0.87
Data from an alpha-fetoprotein pilot screening program in Maine. Obstet Gynecol (1983) 0.86
Maternal serum screening for Down syndrome in the United States: a 1995 survey. Am J Obstet Gynecol (1997) 0.86
Serum triglyceride: a possible risk factor for ruptured abdominal aortic aneurysm. Int J Epidemiol (1998) 0.85
Congenital sensory neuropathy in siblings. Pediatrics (1970) 0.85
Perinatal management of ventral wall defects. Obstet Gynecol (1984) 0.85
Reference distributions for the positive acute phase serum proteins, alpha1-acid glycoprotein (orosomucoid), alpha1-antitrypsin, and haptoglobin: a practical, simple, and clinically relevant approach in a large cohort. J Clin Lab Anal (2000) 0.85
Congenital deficiency of alpha-fetoprotein. Am J Obstet Gynecol (1992) 0.85
Effect of cold on muscle potentials and electrolytes. Metabolism (1968) 0.84
Maternal weight adjustment and low serum alpha-fetoprotein values. Lancet (1985) 0.84
Prenatal screening for cystic fibrosis: an updated perspective. Am J Obstet Gynecol (1997) 0.84
Undetectable maternal serum unconjugated estriol levels in the second trimester: risk of perinatal complications associated with placental sulfatase deficiency. Am J Obstet Gynecol (1997) 0.84
Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defects. Obstet Gynecol (1994) 0.83
Long QT syndrome in children: the value of rate corrected QT interval and DNA analysis as screening tests in the general population. J Med Screen (2001) 0.83
Characteristics and regulation of bile salt synthesis and secretion by human hepatoma HepG2 cells. Hepatology (1994) 0.83
Erythrocyte Na flux in a patient with Bartter's syndrome. J Clin Endocrinol Metab (1971) 0.83
Levels of unconjugated estriol and other maternal serum markers in pregnancies with Smith-Lemli-Opitz (RSH) syndrome fetuses. Am J Med Genet (1999) 0.82
Multiple marker screening for Down syndrome in twin pregnancies. Prenat Diagn (1996) 0.82
Use of maternal serum alpha-fetoprotein measurements to screen for Down's syndrome. Clin Obstet Gynecol (1988) 0.81
First-trimester biochemical screening for Down syndrome. Lancet (1988) 0.80
Pregnancy associated plasma protein A as a marker for Down syndrome in the second trimester of pregnancy. Prenat Diagn (1993) 0.80
The relationship between apolipoprotein E and serum oxidation-related variables is apolipoprotein E phenotype dependent. Int J Clin Lab Res (1998) 0.80
Influence of blood donation and iron supplementation on indicators of iron status. Clin Chem (1994) 0.80
Cystic fibrosis: selecting the prenatal screening strategy of choice. Prenat Diagn (2003) 0.80
Tract elements in health and disease. Practitioner (1968) 0.80
Gastric bypass surgery as maternal risk factor for neural tube defects. Lancet (1988) 0.79
Screening for neural tube defects in the United States. A summary of the Scarborough Conference. Am J Obstet Gynecol (1979) 0.79
Amniotic fluid gel cholinesterase density ratios in fetal open defects of the neural tube and ventral wall. Br J Obstet Gynaecol (1983) 0.78
Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screening. Obstet Gynecol (1993) 0.78
Iodine sufficiency and measurements of thyroid function in maternal hypothyroidism. Clin Endocrinol (Oxf) (2003) 0.78
Circulating cell free DNA testing: are some test failures informative? Prenat Diagn (2015) 0.78
Age-related prevalence of down syndrome. Am J Obstet Gynecol (1999) 0.78
Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements. Am J Obstet Gynecol (1995) 0.78
Elevated serum acute phase protein levels as predictors of disseminated breast cancer. Cancer (1983) 0.78
Coma produced by topical application of isopropanol. Pediatrics (1969) 0.77
Can reliable Down's syndrome detection rates be determined from prenatal screening intervention trials? J Med Screen (1996) 0.77